173 related articles for article (PubMed ID: 37400043)
1. Prospect of targeting lysine methyltransferase NSD3 for tumor therapy.
Li D; Tian T; Ko CN; Yang C
Pharmacol Res; 2023 Aug; 194():106839. PubMed ID: 37400043
[TBL] [Abstract][Full Text] [Related]
2. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth.
Sun Y; Xie J; Cai S; Wang Q; Feng Z; Li Y; Lu JJ; Chen W; Ye Z
Cell Death Dis; 2021 Oct; 12(10):913. PubMed ID: 34615858
[TBL] [Abstract][Full Text] [Related]
4. NSD3: Advances in cancer therapeutic potential and inhibitors research.
Xiu S; Chi X; Jia Z; Shi C; Zhang X; Li Q; Gao T; Zhang L; Liu Z
Eur J Med Chem; 2023 Aug; 256():115440. PubMed ID: 37182335
[TBL] [Abstract][Full Text] [Related]
5. Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase.
Rathert P
Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440470
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel class inhibitors of NSD3 methyltransferase showing a unique, bivalent binding mode in the SET domain.
Kim S; Hwang I; Kim SH; Chung HW; Ji MJ; Moon S; Park HM; Kong G; Hur W
Chem Biol Drug Des; 2023 Sep; 102(3):500-513. PubMed ID: 37072259
[TBL] [Abstract][Full Text] [Related]
7. [NSD3 suppresses LPS-triggered TNF-α production via promoting the dimethylation of histone H3K36 in macrophages].
Liu Z; Cheng Q; Yang L; Sun Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jun; 34(6):481-487. PubMed ID: 30236198
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferase.
Sun Y; Zhang Y; Chen X; Yu A; Du W; Huang Y; Wu F; Yu L; Li J; Wen C; Yang H; Shi Q; Geng M; Huang X; Xu S
Eur J Med Chem; 2022 Sep; 239():114528. PubMed ID: 35717870
[TBL] [Abstract][Full Text] [Related]
9. The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.
Topchu I; Pangeni RP; Bychkov I; Miller SA; Izumchenko E; Yu J; Golemis E; Karanicolas J; Boumber Y
Cell Mol Life Sci; 2022 May; 79(6):285. PubMed ID: 35532818
[TBL] [Abstract][Full Text] [Related]
10. NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.
Nuñez Y; Vera S; Baeza V; Gonzalez-Pecchi V
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256018
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of NSD3 (WHSC1L1) inhibits cell proliferation and migration via ERK1/2 deactivation and decreasing CAPG expression in colorectal cancer cells.
Yi L; Yi L; Liu Q; Li C
Onco Targets Ther; 2019; 12():3933-3943. PubMed ID: 31190890
[No Abstract] [Full Text] [Related]
12. Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.
Xiong J; Pecchi VG; Qui M; Ivanov AA; Mo X; Niu Q; Chen X; Fu H; Du Y
Assay Drug Dev Technol; 2018; 16(2):96-106. PubMed ID: 29634317
[TBL] [Abstract][Full Text] [Related]
13. Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis.
Liu Z; Piao L; Zhuang M; Qiu X; Xu X; Zhang D; Liu M; Ren D
Oncol Rep; 2017 Nov; 38(5):2796-2802. PubMed ID: 28901481
[TBL] [Abstract][Full Text] [Related]
14. The role of histone lysine methyltransferase NSD3 in cancer.
Han X; Piao L; Zhuang Q; Yuan X; Liu Z; He X
Onco Targets Ther; 2018; 11():3847-3852. PubMed ID: 30013365
[TBL] [Abstract][Full Text] [Related]
15. Elevated NSD3 histone methylation activity drives squamous cell lung cancer.
Yuan G; Flores NM; Hausmann S; Lofgren SM; Kharchenko V; Angulo-Ibanez M; Sengupta D; Lu X; Czaban I; Azhibek D; Vicent S; Fischle W; Jaremko M; Fang B; Wistuba II; Chua KF; Roth JA; Minna JD; Shao NY; Jaremko Ł; Mazur PK; Gozani O
Nature; 2021 Feb; 590(7846):504-508. PubMed ID: 33536620
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
Li W; Tian W; Yuan G; Deng P; Sengupta D; Cheng Z; Cao Y; Ren J; Qin Y; Zhou Y; Jia Y; Gozani O; Patel DJ; Wang Z
Nature; 2021 Feb; 590(7846):498-503. PubMed ID: 33361816
[TBL] [Abstract][Full Text] [Related]
17. The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3.
Wang C; Wang Q; Xu X; Xie B; Zhao Y; Li N; Cao X
J Exp Med; 2017 Dec; 214(12):3597-3610. PubMed ID: 29101251
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the C-terminus of the histone-lysine N-methyltransferase NSD3 by small-angle X-ray scattering.
Belviso BD; Shen Y; Carrozzini B; Morishita M; di Luccio E; Caliandro R
Front Mol Biosci; 2024; 11():1191246. PubMed ID: 38516186
[TBL] [Abstract][Full Text] [Related]
19. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
[TBL] [Abstract][Full Text] [Related]
20. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.
Rahman S; Sowa ME; Ottinger M; Smith JA; Shi Y; Harper JW; Howley PM
Mol Cell Biol; 2011 Jul; 31(13):2641-52. PubMed ID: 21555454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
